New Horizons in the Management of Dyslipidemias
- PMID: 38290480
- DOI: 10.1159/000535878
New Horizons in the Management of Dyslipidemias
Keywords: Cardiovascular outcomes; Cholesterol-lowering therapy; Dyslipidemia; HMGCoAreductase inhibition.
Similar articles
-
Do acute coronary events affect lipid management and cholesterol goal attainment in Germany? : Results from the Dyslipidemia International study II.Wien Klin Wochenschr. 2018 Dec;130(23-24):707-715. doi: 10.1007/s00508-018-1375-3. Epub 2018 Sep 3. Wien Klin Wochenschr. 2018. PMID: 30178071 Free PMC article.
-
New treatment options for lipid-lowering therapy in subjects with type 2 diabetes.Acta Diabetol. 2018 Mar;55(3):209-218. doi: 10.1007/s00592-017-1089-4. Epub 2017 Dec 19. Acta Diabetol. 2018. PMID: 29260404 Review.
-
New Recommendations and Revised Concepts in Recent Guidelines on the Management of Dyslipidemias to Prevent Cardiovascular Disease: the 2018 ACC/AHA and 2019 ESC/EAS Guidelines.Curr Cardiol Rep. 2020 Jul 9;22(9):87. doi: 10.1007/s11886-020-01331-z. Curr Cardiol Rep. 2020. PMID: 32647997 Review.
-
IL-1β inhibition combined with cholesterol-lowering therapies decreases synovial lining thickness and spontaneous cartilage degeneration in a humanized dyslipidemia mouse model.Osteoarthritis Cartilage. 2023 Mar;31(3):340-350. doi: 10.1016/j.joca.2022.09.014. Epub 2022 Nov 25. Osteoarthritis Cartilage. 2023. PMID: 36442605
-
Endothelial Function in Dyslipidemia: Roles of LDL-Cholesterol, HDL-Cholesterol and Triglycerides.Cells. 2023 May 1;12(9):1293. doi: 10.3390/cells12091293. Cells. 2023. PMID: 37174693 Free PMC article. Review.
LinkOut - more resources
Full Text Sources